HN2010002157A - Antagonistas de la trayectoria hedgehog de ftalazina disustituida - Google Patents
Antagonistas de la trayectoria hedgehog de ftalazina disustituidaInfo
- Publication number
- HN2010002157A HN2010002157A HN2010002157A HN2010002157A HN2010002157A HN 2010002157 A HN2010002157 A HN 2010002157A HN 2010002157 A HN2010002157 A HN 2010002157A HN 2010002157 A HN2010002157 A HN 2010002157A HN 2010002157 A HN2010002157 A HN 2010002157A
- Authority
- HN
- Honduras
- Prior art keywords
- hedgehog
- antagonists
- ftalazina
- disttituted
- history
- Prior art date
Links
- 241000027355 Ferocactus setispinus Species 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000030968 tissue homeostasis Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4872908P | 2008-04-29 | 2008-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2010002157A true HN2010002157A (es) | 2014-09-08 |
Family
ID=40846962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2010002157A HN2010002157A (es) | 2008-04-29 | 2010-10-21 | Antagonistas de la trayectoria hedgehog de ftalazina disustituida |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7981892B2 (https=) |
| EP (1) | EP2294061A2 (https=) |
| JP (1) | JP5442717B2 (https=) |
| KR (1) | KR101260116B1 (https=) |
| CN (1) | CN102066353B (https=) |
| AU (1) | AU2009241561B2 (https=) |
| BR (1) | BRPI0911618A2 (https=) |
| CA (1) | CA2723042A1 (https=) |
| CO (1) | CO6300945A2 (https=) |
| CR (1) | CR11741A (https=) |
| DO (1) | DOP2010000302A (https=) |
| EA (1) | EA201071248A1 (https=) |
| EC (1) | ECSP10010577A (https=) |
| HN (1) | HN2010002157A (https=) |
| IL (1) | IL208211A0 (https=) |
| MA (1) | MA32349B1 (https=) |
| MX (1) | MX2010011948A (https=) |
| MY (1) | MY159491A (https=) |
| NZ (1) | NZ588001A (https=) |
| UA (1) | UA102250C2 (https=) |
| WO (1) | WO2009134574A2 (https=) |
| ZA (1) | ZA201006695B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA102250C2 (ru) | 2008-04-29 | 2013-06-25 | Эли Лилли Энд Компани | Двухзамещенные фталазины - антагонисты проводящего пути hedgehog |
| EP2364185B1 (en) | 2008-11-03 | 2013-05-22 | Eli Lilly And Company | Disubstituted phthalazine hedgehog pathway antagonists |
| MX2011005176A (es) | 2008-11-17 | 2011-05-30 | Lilly Co Eli | Antagonistas de la trayectoria hedgehog de piridazinas tetrasustituidas. |
| CA2743483C (en) | 2008-11-17 | 2014-03-11 | Eli Lilly And Company | Tetrasubstituted pyridazine hedgehog pathway antagonists |
| AR077014A1 (es) * | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
| CA2781210A1 (en) * | 2009-11-18 | 2011-05-26 | Novartis Ag | Methods and compositions for treating solid tumors and other malignancies |
| CN102702108A (zh) * | 2012-06-27 | 2012-10-03 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
| EP2895474B1 (en) * | 2012-09-17 | 2019-12-11 | Duke University | Smoothened receptor modulators and methods of use thereof |
| CN102863393A (zh) * | 2012-09-26 | 2013-01-09 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
| GB201309508D0 (en) | 2013-05-28 | 2013-07-10 | Redx Pharma Ltd | Compounds |
| GB2528298A (en) * | 2014-07-16 | 2016-01-20 | Redx Pharma Plc | Compounds |
| CN105985321B (zh) * | 2015-02-11 | 2018-10-26 | 复旦大学 | 吡唑酞嗪化合物及其制备方法和用途 |
| CN105985320B (zh) * | 2015-02-11 | 2018-10-26 | 复旦大学 | 苄基酞嗪化合物及其制备方法和用途 |
| CN105985319B (zh) * | 2015-02-11 | 2019-02-26 | 复旦大学 | 芳基酞嗪化合物及其制备方法和用途 |
| CN107163028B (zh) * | 2017-05-24 | 2019-07-12 | 东南大学 | 一种苯甲酰胺类Hedgehog抑制剂及其制备方法和应用 |
| US12605377B2 (en) | 2020-10-13 | 2026-04-21 | Endeavor Biomedicines, Inc. | Methods of treating fibrosis |
| JP2023546536A (ja) | 2020-10-13 | 2023-11-02 | エンデバー バイオメディシンズ， インコーポレイテッド | 線維症を処置する方法 |
| GEAP202516743A (en) * | 2022-09-23 | 2025-08-11 | Merck Sharp & Dohme Llc | Phthalazine derivatives useful as inhibitors of nod-like receptor protein 3 |
| WO2025188802A1 (en) | 2024-03-05 | 2025-09-12 | Endeavor Biomedicines, Inc. | Methods of improving lung function |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
| ATE203534T1 (de) * | 1996-01-15 | 2001-08-15 | Janssen Pharmaceutica Nv | Angiogenesis hemmende pyridazinamine |
| IL138645A0 (en) | 1998-04-09 | 2001-10-31 | Univ Johns Hopkins Med | Use of steroidal alkaloid derivatives as inhibitors of hedghog signalling pathways |
| US6432970B2 (en) * | 1998-04-09 | 2002-08-13 | Johns Hopkins University School Of Medicine | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto |
| CA2376210A1 (en) | 1999-06-08 | 2000-12-14 | Lorantis Limited | Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| DE60322869D1 (de) | 2002-04-22 | 2008-09-25 | Univ Johns Hopkins | Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen |
| AU2003265853A1 (en) | 2002-08-29 | 2004-03-19 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
| US8067608B2 (en) * | 2003-09-29 | 2011-11-29 | The Johns Hopkins University | Hedgehog pathway antagonists |
| TW200533356A (en) | 2004-02-24 | 2005-10-16 | Mitsubishi Pharma Corp | Fused pyridazine derivatives |
| EP1745039A4 (en) | 2004-05-08 | 2009-07-22 | Neurogen Corp | 3-ARYL-5,6-DISUBSTITUTED PYRIDAZINES |
| DK1789390T3 (da) | 2004-09-02 | 2012-02-27 | Genentech Inc | Pyridyl-inhibitorer af hedgehog-signalering |
| EP1900731A1 (de) | 2006-09-07 | 2008-03-19 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren |
| PE20090188A1 (es) * | 2007-03-15 | 2009-03-20 | Novartis Ag | Compuestos heterociclicos como moduladores de la senda de hedgehog |
| US8153633B2 (en) * | 2007-06-25 | 2012-04-10 | Amgen Inc. | Phthalazine compounds, compositions and methods of use |
| WO2009035568A1 (en) | 2007-09-07 | 2009-03-19 | Amgen Inc. | Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling |
| UA102250C2 (ru) | 2008-04-29 | 2013-06-25 | Эли Лилли Энд Компани | Двухзамещенные фталазины - антагонисты проводящего пути hedgehog |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| EP2364185B1 (en) | 2008-11-03 | 2013-05-22 | Eli Lilly And Company | Disubstituted phthalazine hedgehog pathway antagonists |
| MX2011005176A (es) | 2008-11-17 | 2011-05-30 | Lilly Co Eli | Antagonistas de la trayectoria hedgehog de piridazinas tetrasustituidas. |
| CA2743483C (en) | 2008-11-17 | 2014-03-11 | Eli Lilly And Company | Tetrasubstituted pyridazine hedgehog pathway antagonists |
| AR077014A1 (es) * | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
-
2009
- 2009-04-01 UA UAA201012722A patent/UA102250C2/ru unknown
- 2009-04-01 CA CA2723042A patent/CA2723042A1/en not_active Abandoned
- 2009-04-01 JP JP2011507512A patent/JP5442717B2/ja not_active Expired - Fee Related
- 2009-04-01 MX MX2010011948A patent/MX2010011948A/es active IP Right Grant
- 2009-04-01 EA EA201071248A patent/EA201071248A1/ru unknown
- 2009-04-01 BR BRPI0911618A patent/BRPI0911618A2/pt not_active IP Right Cessation
- 2009-04-01 KR KR1020107024209A patent/KR101260116B1/ko not_active Expired - Fee Related
- 2009-04-01 US US12/935,655 patent/US7981892B2/en not_active Expired - Fee Related
- 2009-04-01 NZ NZ588001A patent/NZ588001A/en not_active IP Right Cessation
- 2009-04-01 WO PCT/US2009/039065 patent/WO2009134574A2/en not_active Ceased
- 2009-04-01 CN CN2009801152085A patent/CN102066353B/zh not_active Expired - Fee Related
- 2009-04-01 EP EP09739376A patent/EP2294061A2/en not_active Withdrawn
- 2009-04-01 AU AU2009241561A patent/AU2009241561B2/en not_active Ceased
- 2009-04-01 MY MYPI2010005097A patent/MY159491A/en unknown
-
2010
- 2010-09-16 IL IL208211A patent/IL208211A0/en unknown
- 2010-09-17 ZA ZA2010/06695A patent/ZA201006695B/en unknown
- 2010-10-11 DO DO2010000302A patent/DOP2010000302A/es unknown
- 2010-10-15 CR CR11741A patent/CR11741A/es unknown
- 2010-10-21 HN HN2010002157A patent/HN2010002157A/es unknown
- 2010-10-25 MA MA33284A patent/MA32349B1/fr unknown
- 2010-10-27 EC EC2010010577A patent/ECSP10010577A/es unknown
- 2010-11-11 CO CO10141824A patent/CO6300945A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP10010577A (es) | 2010-11-30 |
| ZA201006695B (en) | 2012-09-26 |
| KR20100126580A (ko) | 2010-12-01 |
| KR101260116B1 (ko) | 2013-05-02 |
| AU2009241561B2 (en) | 2013-05-16 |
| WO2009134574A2 (en) | 2009-11-05 |
| EP2294061A2 (en) | 2011-03-16 |
| DOP2010000302A (es) | 2010-11-15 |
| CA2723042A1 (en) | 2009-11-05 |
| CR11741A (es) | 2011-01-05 |
| EA201071248A1 (ru) | 2011-06-30 |
| CO6300945A2 (es) | 2011-07-21 |
| JP5442717B2 (ja) | 2014-03-12 |
| AU2009241561A1 (en) | 2009-11-05 |
| WO2009134574A3 (en) | 2014-09-04 |
| CN102066353A (zh) | 2011-05-18 |
| US20110046143A1 (en) | 2011-02-24 |
| MA32349B1 (fr) | 2011-06-01 |
| MX2010011948A (es) | 2010-12-14 |
| CN102066353B (zh) | 2013-12-11 |
| BRPI0911618A2 (pt) | 2019-09-24 |
| JP2011527666A (ja) | 2011-11-04 |
| UA102250C2 (ru) | 2013-06-25 |
| IL208211A0 (en) | 2010-12-30 |
| NZ588001A (en) | 2012-06-29 |
| US7981892B2 (en) | 2011-07-19 |
| MY159491A (en) | 2017-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HN2010002157A (es) | Antagonistas de la trayectoria hedgehog de ftalazina disustituida | |
| CL2019002067A1 (es) | Isoquinolin-3-il-carboxamidas, y preparación y uso de las mismas. (divisional solicitud 201803050). | |
| ECSP077985A (es) | Inhibidores de proteina cinasa derivados de pirrol (2,3-b) piridina | |
| CR20120051A (es) | Derivados de piridina y pirazina como moduladores de cinasa de proteína | |
| UY31126A1 (es) | Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus | |
| CY1120054T1 (el) | Ετεροκυκλικες ενωσεις για τη θεραπευτικη αντιμετωπιση νευρολογικων και ψυχολογικων διαταραχων | |
| MX2019003829A (es) | Compuestos de benzo[b]tiofeno como agonistas de sting. | |
| BRPI0912542A2 (pt) | derivados de ácido 3,5-diamino-cloro-pirazina-2-carboxílico e seu uso como bloqueadores do canal de sódio epitelial para o tratamento de vias aéreas. | |
| MX381313B (es) | Derivados de benzimidazol como moduladores de ror-gamma | |
| MX378957B (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la ret quinasa | |
| UY29186A1 (es) | Nuevas piridinureas de antranilamida como inhibidores de la quinasa receptora del factor de crecimiento vascular endotelial (vegf) | |
| MX372722B (es) | Sulfonamidas de aza-aril 1h-pirazol-1-il benceno | |
| ECSP10010582A (es) | Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer | |
| MX375715B (es) | Profarmacos de metilfenidato, procesos de elaboración y uso de los mismos. | |
| MX339709B (es) | Antagonistas de wnt y metodos de tratamiento y analisis. | |
| UY34539A (es) | Heteroarilos y usos de los mismos | |
| MX2012013945A (es) | Nuevas formas de rifaximina y usos de las mismas. | |
| UY30835A1 (es) | 8-alquinilxantinas y derivados | |
| CO2018007278A2 (es) | Derivados de ácido aminobenzoico metaazacíclico como antagonistas de la integrina pan | |
| EA201200578A1 (ru) | Сульфоксидные производные для лечения опухолей | |
| UY35344A (es) | Oestra-1,3,5(10),16-tetraeno-3-carboxamidas | |
| UY34043A (es) | Isoxazolinas como agentes terapéuticos | |
| ECSP11011482A (es) | Piperidinas sustituidas | |
| BRPI0614397A2 (pt) | compostos de pirimidina como moduladores de receptor de serotonina | |
| UY34543A (es) | Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica. |